Stand Up To Cancer - standuptocancer.orgThis is where the end of cancer begins
   Please leave this field empty

In The News

Share this:
Email

Like this page on Facebook


SU2C-supported researchers find novel strategy in combination drug therapy

A research team supported in part by SU2C has published findings that show how we may be able to kill cancerous cells more effectively by combining drugs that work together to significantly disrupt a cancer cell’s ability to survive DNA damage. These findings are the first to show this combination drug therapy as a novel approach for treating acute myeloid leukemia (AML) and potentially, many other cancers.

+ More



SU2C supported clinical trial shows promise with immunotherapy and lung cancer

SU2C supported clinical trial shows promise with immunotherapy and lung cancer

+ More



Q&A with SU2C scientist on stem cells and brain cancer

Q&A with SU2C scientist on stem cells and brain cancer

+ More



Employees of Bristol-Myers Squibb are riding to support SU2C cancer research

Employees of Bristol-Myers Squibb are riding to support SU2C cancer research

+ More



Ten new scientists join SU2C to achieve high-risk, high-reward projects

Ten new scientists join SU2C to achieve high-risk, high-reward projects

+ More


Innovate Collaborate Accelerate